Recon: FDA clears Pfizer booster for 12- to 15-year-olds; Teva found liable in New York opioid trial
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy